SCHEMBL17826113

SCHEMBL17826113

C=C(c1ccc(-c2cncc(-c3nnc(NC)o3)n2)cc1)N(C)C

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 18/20 0.52
▸ ALOX15 P16050 1/20 0.34
▸ CHEK1 O14757 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17826204 0.87 ATR (0.56) ATRCHEK1
SCHEMBL16420532 0.86 ATR (0.69) ATR
SCHEMBL17826112 0.86 ATR (0.55) ATR
SCHEMBL17826117 0.84 ATR (0.57) ATR
SCHEMBL17826123 0.83 ATR (0.57) ATR
SCHEMBL17826210 0.83 ATR (0.59) ATRALOX15
SCHEMBL17826167 0.83 ATR (0.57) ATR
SCHEMBL17826122 0.83 ATR (0.59) ATR
SCHEMBL17826158 0.82 ATR (0.58) ATR
SCHEMBL17826200 0.82 ATR (0.51) ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365557-B2 Substituted pyrazin-2-amines as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-06-14 — — US disclosed
Send feedback